Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05275673
Title A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Calithera Biosciences, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC Davis Comprehensive Cancer Center Davis California 95817 United States Details
Providence Medical Group Santa Rosa - Cancer Center Santa Rosa California 95403 United States Details
Florida Cancer Specialists Fort Myers Florida 33901 United States Details
Ocala Oncology Center Ocala Florida 34474 United States Details
Florida Cancer Specialists Tallahassee Florida 32308 United States Details
Norton Cancer Institute, Downtown Louisville Kentucky 40202 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Washington University - Patient Care Coordinator Center Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center - Thoracic New York New York 10065 United States Details
Zangmeister Cancer Center Columbus Ohio 43219 United States Details
Providence Cancer Institute Franz Clinic Portland Oregon 97213 United States Details
UPMC Cancer Pavilion Pittsburgh Pennsylvania 15232 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Virginia Cancer Specialist, PC Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field